Use of High-Sensitivity Cardiac Troponin in Patients With Kidney Impairment: A Randomized Clinical Trial
- PMID: 34096969
- PMCID: PMC8185626
- DOI: 10.1001/jamainternmed.2021.1184
Use of High-Sensitivity Cardiac Troponin in Patients With Kidney Impairment: A Randomized Clinical Trial
Abstract
This randomized clinical trial examines the use of high-sensitivity cardiac troponin testing for patients with kidney impairment.
Conflict of interest statement
Figures

Comment in
-
High-Sensitivity Cardiac Troponin Assay in Patients With Kidney Impairment: A Challenge to Clinical Implementation.JAMA Intern Med. 2021 Sep 1;181(9):1239-1241. doi: 10.1001/jamainternmed.2021.1194. JAMA Intern Med. 2021. PMID: 34096967 No abstract available.
References
-
- Thygesen K, Alpert JS, Jaffe AS, et al. ; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction . Fourth universal definition of myocardial infarction (2018). J Am Coll Cardiol. 2018;72(18):2231-2264. doi:10.1016/j.jacc.2018.08.1038 - DOI - PubMed
-
- Shah ASV, Anand A, Strachan FE, et al. ; High-STEACS Investigators . High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial. Lancet. 2018;392(10151):919-928. doi:10.1016/S0140-6736(18)31923-8 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical